InvestorsHub Logo
Followers 437
Posts 18558
Boards Moderated 0
Alias Born 09/10/2000

Re: None

Tuesday, 05/07/2024 11:19:25 AM

Tuesday, May 07, 2024 11:19:25 AM

Post# of 3271
Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced it has received a Bid Price Compliance Letter from The Nasdaq Stock Market LLC ("Nasdaq") informing Windtree that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market.

The Dog that doesn't bark is the one to pay attention to

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent WINT News